Newsletter | November 11, 2024

11.11.24 -- What Is There to Learn from a Combination Products Handbook? Plenty!

SPONSOR

Nanotechnology To Improve The Performance Of Your Small And Large Molecule Medicines

Christian Jones shares the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations through superior bioavailability, drug loading, route of administration, pill burden, and more.

FEATURED EDITORIAL

What Is There To Learn From A Combination Products Handbook? Plenty!

In this initial episode, host Tom von Gunden discusses the book’s intent with its editor, Susan Neadle. The discussion focuses on the rationale for each chapter and the expert contributions of various chapter authors and co-authors.

Defining And Regulating Combination Products: An Evolutionary Journey

Here, host Tom von Gunden discusses Chapter 1 of The Combination Products Handbook: A Practical Guide for Combination Products and Other Combined Use Systems (CRC Press, 2023) with the book’s editor, Susan Neadle. Given that the initial chapter was penned by the FDA’s John “Barr” Weiner, the discussion focuses on reasons for establishing the historical and regulatory context for combination products early in the handbook’s topic coverage.

INDUSTRY INSIGHTS

Revised EU Annex 1: Shaping The Future Of Drug Delivery

The revisions to EU Annex 1 set the stage for the future direction of the pharma/biotech industry. Explore some of the key takeaways and interesting changes for risk management and contamination control.

New Perspectives On Accelerating Genetic Nanomedicines

Discover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.

Driving Drug Delivery Innovation Through Client-Centric Services

Transitioning from a product-based to a service-based organization helped a leading CDMO commit to client-centricity and operational excellence and meet the evolving needs of the pharmaceutical industry.

Unlocking A Patient Preference For Rapid Onset In Treating Migraines

Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.

Collaborating With A CMO To Bring Your Sterile Injectable Product To Market

Review considerations for collaborating with a fill/finish CMO, including CMO selection, Request for Proposal (RFP) delivery, proposal review, and project award.

PBPK Modeling: Mitigating Absorption Risks In Early Drug Development

Watch how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

SOLUTIONS

Solvent-Free, Fusion-Based Amorphic Dispersion Process

Glass Prefillable Syringe Solution Delivering Complex Biologics

Automated Vision Inspection Systems For Injectable Drug Products